DHR vs SLRX · P/E 39, rev $6.26B vs $4.9M cap
Danaher Corporation (DHR) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the DHR and SLRX stock pages for the full models.
Not investment advice.